Evidence map›Paper›PMID 35745821›Full record

ArticlePharmaceutics2022

Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies.

Mariana P Nucci, Javier B Mamani, Fernando A Oliveira, Igor S Filgueiras, Arielly H Alves, Matheus H Theinel, Luiz D Rodrigues, Luciana Marti, Lionel F Gamarra

Abstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mariana P NucciHospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-1502-9215
Javier B MamaniHospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0001-5038-0070
Fernando A OliveiraHospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-7226-1694
Igor S FilgueirasHospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-3493-4464
Arielly H AlvesHospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.
Matheus H TheinelHospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.
Luiz D RodriguesFaculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo, São Paulo 05508-270, Brazil.
Luciana MartiHospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-3890-0827
Lionel F GamarraHospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-3910-0047

Funding

Amigos da Oncologia e Hematologia Einstein" AMIGOH 001National Council for Scientific and Technological Development 308901/2020, 465259/2014-6, 400856/2016-6São Paulo Research Foundation 2019/21070-3, 2017/17868-4, 2016/21470-3SisNANO 2.0/MCTIC 442539/2019-3
6 · The paper itself

Abstract

Considering there are several difficulties and limitations in labeling stem cells using multifunctional nanoparticles (MFNP), the purpose of this study was to determine the optimal conditions for labeling human bone marrow mesenchymal stem cells (hBM-MSC), aiming to monitor these cells in vivo. Thus, this study provides information on hBM-MSC direct labeling using multimodal nanoparticles in terms of concentration, magnetic field, and period of incubation while maintaining these cells' viability and the homing ability for in vivo experiments. The cell labeling process was assessed using 10, 30, and 50 µg Fe/mL of MFNP, with periods of incubation ranging from 4 to 24 h, with or without a magnetic field, using optical microscopy, near-infrared fluorescence (NIRF), and inductively coupled plasma mass spectrometry (ICP-MS). After the determination of optimal labeling conditions, these cells were applied in vivo 24 h after stroke induction, intending to evaluate cell homing and improve NIRF signal detection. In the presence of a magnetic field and utilizing the maximal concentration of MFNP during cell labeling, the iron load assessed by NIRF and ICP-MS was four times higher than what was achieved before. In addition, considering cell viability higher than 98%, the recommended incubation time was 9 h, which corresponded to a 25.4

Indexed as

bioluminescencecell therapyICP-MSincubation timelabelingmagnetic fieldmesenchymal stem cellmultimodal nanoparticlenear-infrared fluorescence imagestroke

Identifiers

PMID35745821
PMCPMC9227698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.